Switch to:
More From Other Websites
Is Johnson & Johnson’s Valuation High Compared to Its Peers? Aug 30 2016
[$$] Why Investors Should Think Global Aug 26 2016
AstraZeneca’s Recent Product Developments Aug 25 2016
AstraZeneca and Its Oncology Segment’s Growth in 2Q16 Aug 25 2016
How Crestor Weakened AstraZeneca’s CVMD Segment in 2Q16 Aug 24 2016
Remicade Is Driving Down Merck’s Immunology Franchise Aug 16 2016
How Are Eli Lilly’s New Products Performing? Aug 04 2016
Revenues from Eli Lilly’s Cymbalta Are Depressed Internationally Aug 03 2016
What to Expect from Pfizer’s 2Q16 Earnings Aug 01 2016
How Did JNJ’s Pharmaceutical Segment Fare in 2Q16? Jul 22 2016
Understanding Lilly’s New Product Expectations for 2Q16 Jul 22 2016
Inside Lilly’s 2Q16 Estimates for Its Neuroscience Franchise Jul 22 2016
Why AbbVie Continues to Explore Imbruvica for Diffuse Large B-Cell Lymphoma Jul 06 2016
AstraZeneca’s Key Focus: Oncology Jun 06 2016
What’s AstraZeneca’s Largest Revenue Contributor? Jun 01 2016
Government Study: Cellphone Radiation Linked To Cancer May 27 2016
Recovery for the Manufacturing Sector Is Not Yet in Sight May 18 2016
Why Is Remicade Driving Down Merck’s Performance? May 16 2016


No Entry for this criteria! We are updating our databases daily, please come back later!

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK